Fund 13F filing

FARALLON CAPITAL MANAGEMENT, L.L.C. cut $73.3M of Vaxcyte, Inc. (PCVX) stock

SEC Form 13F · Filed Aug 14, 2026

FARALLON CAPITAL MANAGEMENT, L.L.C. cut $73.3M of Vaxcyte, Inc. (PCVX) stock in the quarter ending Jun 30, 2026, per a 13F filed Aug 14, 2026.

A 13F shows holdings at quarter end, so the exact trade dates are not disclosed.

Sold

Vaxcyte, Inc.

Value

$73.3M

More PCVX insider and Congress trades

Share this trade

From a public SEC Form 13F, linked above. Not investment advice, and not a recommendation to buy or sell.